// App-Quantinova.ai

7017 : Mitochondrial profiling as a predictive biomarker for response to cytarabine-based treatment of acute myelogenous leukemia.

Researchers

Presenter

  • E.J. Dettman

Principal Investigators

  • Camille Doykan

  • Michael H. Cardone

  • Robert Hills

  • Paul White

  • Alan Kenneth Burnett

  • Michael Andreeff

Medical Centers

  • Eutropics Pharmaceuticals, Cambridge, MA

  • Eutropics, Inc., Cambridge, MA

  • Cardiff University School of Medicine, Cardiff, United Kingdom

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

  • United Kingdom

Companies

  • Eutropics Pharmaceut

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • B-cell lymphoma 2

  • BCL2 like 11

Drug/Treatment

  • Cytarabine liposomal

  • ara-c

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved